Bruker Corporation (BRKR) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Total Assets Chart for Bruker Corporation
Bruker Corporation (BRKR) total assets for FY2025 were USD 6.2B, a 7.5% change from FY2024. Bruker Corporation's total assets grew from USD 63.8M in 1998 to USD 6.2B in 2025 (9676.5% over 27 years). Total assets compound annual growth rate: 5-year CAGR of 15.4%, 10-year CAGR of 13.7%, 20-year CAGR of 15.3%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $9.22B
- Implied Share Price
- $60.50
- Enterprise Value
- $10.69B
- Revenue (TTM)
- $3.50B
- EBITDA
- $541.10M
- Profit Margin
- -2.04%
- Trailing P/E
- —
- Forward P/E
- 13.83
- Price/Book (MRQ)
- 3.82
- Price/Sales (TTM)
- 2.63
- EV/EBITDA
- 39.72
- EV/Revenue
- 3.06
- Dividend Yield
- 0.31%
- Book Value
- $15.63
- Free Cash Flow (FY2025)
- $13.90M
- Free Cash Flow Yield
- 0.15%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.